{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T19:40:03Z","timestamp":1773862803317,"version":"3.50.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"K\u00fctahya Health Sciences University Scientific Research Projects Coordination Unit","award":["185"],"award-info":[{"award-number":["185"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-11682-5","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T12:14:38Z","timestamp":1773836078000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cell line-specific antileukemic effects of imipramine: apoptosis, reactive oxygen species modulation and cytokine responses in human acute promyelocytic leukemia and chronic myelogenous leukemia cells"],"prefix":"10.1007","volume":"53","author":[{"given":"Neslihan","family":"Meri\u00e7","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ezgi","family":"Kar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatih","family":"Kar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,18]]},"reference":[{"issue":"2","key":"11682_CR1","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3758\/s13415-024-01171-2","volume":"24","author":"S Gencturk","year":"2024","unstructured":"Gencturk S, Unal G (2024) Rodent tests of depression and anxiety: Construct validity and translational relevance. Cogn Affect Behav Neurosci 24(2):191\u2013224. https:\/\/doi.org\/10.3758\/s13415-024-01171-2","journal-title":"Cogn Affect Behav Neurosci"},{"issue":"2","key":"11682_CR2","doi-asserted-by":"publisher","first-page":"69","DOI":"10.21502\/limuj.008.01.2016","volume":"1","author":"S Aburawi","year":"2016","unstructured":"Aburawi S, Baayo S (2016) The effect of imipramine on the behavior of albino mice in presence of selenium. Libyan Int Med Univ J 1(2):69\u201381","journal-title":"Libyan Int Med Univ J"},{"issue":"11\u201312","key":"11682_CR3","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/j.jchromb.2009.02.070","volume":"877","author":"MJ Yoo","year":"2009","unstructured":"Yoo MJ, Smith QR, Hage DS (2009) Studies of imipramine binding to human serum albumin by high-performance affinity chromatography. J Chromatogr B Anal Technol Biomed Life Sci 877(11\u201312):1149\u20131154","journal-title":"J Chromatogr B Anal Technol Biomed Life Sci"},{"issue":"2","key":"11682_CR4","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.bbrc.2011.08.093","volume":"413","author":"S-H Jeon","year":"2011","unstructured":"Jeon S-H et al (2011) The tricyclic antidepressant imipramine induces autophagic cell death in U-87MG glioma cells. Biochem Biophys Res Commun 413(2):311\u2013317. https:\/\/doi.org\/10.1016\/j.bbrc.2011.08.093","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"11682_CR5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1159\/000315101","volume":"26","author":"J Kornhuber","year":"2010","unstructured":"Kornhuber J et al (2010) Functional Inhibitors of Acid Sphingomyelinase (FIASMAs): a novel pharmacological group of drugs with broad clinical applications. Cell Physiol Biochem Int J Exp Cell Physiol Biochem Pharmacol 26(1):9\u201320. https:\/\/doi.org\/10.1159\/000315101","journal-title":"Cell Physiol Biochem Int J Exp Cell Physiol Biochem Pharmacol"},{"issue":"Suppl 1","key":"11682_CR6","first-page":"9","volume":"56","author":"AS Horn","year":"1980","unstructured":"Horn AS (1980) The mode of action of tricyclic antidepressants: a brief review of recent progress. Postgrad Med J 56(Suppl 1):9\u201312","journal-title":"Postgrad Med J"},{"key":"11682_CR7","doi-asserted-by":"crossref","unstructured":"Andrade-Neto VV, Pereira TM, Canto-Cavalheiro M (2016) and E. C. Torres-Santos, Imipramine alters the sterol profile in Leishmania amazonensis and increases its sensitivity to miconazole, Parasit Vectors, 9(1):183","DOI":"10.1186\/s13071-016-1467-8"},{"issue":"5","key":"11682_CR8","doi-asserted-by":"publisher","first-page":"602","DOI":"10.3390\/pathogens11050602","volume":"11","author":"L John","year":"2022","unstructured":"John L, Vernersson C, Kwon H, Elling U, Penninger JM, Mirazimi A (2022) Redirecting imipramine against Bluetongue virus infection: Insights from a genome-wide haploid screening study. Pathogens 11(5):602","journal-title":"Pathogens"},{"issue":"7","key":"11682_CR9","doi-asserted-by":"publisher","first-page":"2985","DOI":"10.21873\/anticanres.16469","volume":"43","author":"S-K Chen","year":"2023","unstructured":"Chen S-K, Lee W, Li Y-C, Hsu F-T, Chen W-T (2023) Imipramine induces apoptosis and inhibits the metastatic potential of triple-negative breast cancer cells. Anticancer Res 43(7):2985\u20132994","journal-title":"Anticancer Res"},{"key":"11682_CR10","doi-asserted-by":"publisher","first-page":"735183","DOI":"10.3389\/fonc.2021.735183","volume":"11","author":"P-F Yueh","year":"2021","unstructured":"Yueh P-F et al (2021) Suppression of EGFR\/PKC-\u03b4\/NF-\u03baB signaling associated with imipramine-inhibited progression of non-small cell lung cancer. Front Oncol 11:735183","journal-title":"Front Oncol"},{"issue":"1","key":"11682_CR11","doi-asserted-by":"publisher","first-page":"e14291","DOI":"10.1111\/and.14291","volume":"54","author":"F S\u00f6\u011f\u00fct","year":"2022","unstructured":"S\u00f6\u011f\u00fct F, \u00c7\u00f6meleko\u011flu \u00dc, Dervi\u015fo\u011flu H, Ero\\u glu P, Yalin S, Yilmaz N\u015e (2022) Effect of imipramine on ether \u00e0-go\u2010go potassium channel (Kv1.10) expression in DU145 prostate cancer cells. Andrologia 54(1):e14291","journal-title":"Andrologia"},{"issue":"20","key":"11682_CR12","doi-asserted-by":"publisher","first-page":"4619","DOI":"10.3390\/molecules25204619","volume":"25","author":"EY Lim","year":"2020","unstructured":"Lim EY, Park J, Kim YT, Kim MJ (2020) Imipramine inhibits migration and invasion in metastatic castration-resistant prostate cancer PC-3 cells via AKT-mediated NF-\u03baB signaling pathway. Molecules 25(20):4619","journal-title":"Molecules"},{"issue":"7Supplement","key":"11682_CR13","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1158\/1538-7445.AM2023-1665","volume":"83","author":"PP Venkata","year":"2023","unstructured":"Venkata PP et al (2023) Abstract 1665: Imipramine enhances the efficacy of lomustine by regulating WNT-\u03b2-catenin signaling in glioblastoma. Cancer Res 83(7Supplement):1665. https:\/\/doi.org\/10.1158\/1538-7445.AM2023-1665","journal-title":"Cancer Res"},{"issue":"16Supplement","key":"11682_CR14","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1158\/1538-7445.AM2020-628","volume":"80","author":"P-F Yueh","year":"2020","unstructured":"Yueh P-F, chiang I-T, Hsu F-T (2020) Abstract 628: Imipramine induced apoptosis and inhibits invasion via suppression of EGFR\/ERK\/NF-kappa B activation in non-small cells lung cancer. Cancer Res 80(16Supplement):628. https:\/\/doi.org\/10.1158\/1538-7445.AM2020-628","journal-title":"Cancer Res"},{"issue":"10","key":"11682_CR15","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1158\/0008-5472.CAN-18-2331","volume":"79","author":"E Kim","year":"2019","unstructured":"Kim E et al (2019) Expression Predicts Therapeutic Vulnerability to p300 Inhibition in Human Melanoma. Cancer Res 79(10):2649\u20132661. https:\/\/doi.org\/10.1158\/0008-5472.CAN-18-2331","journal-title":"Cancer Res"},{"issue":"15","key":"11682_CR16","doi-asserted-by":"publisher","first-page":"4775","DOI":"10.1158\/1078-0432.CCR-18-3295","volume":"25","author":"R Ladjohounlou","year":"2019","unstructured":"Ladjohounlou R et al (2019) Drugs That Modify Cholesterol Metabolism Alter the p38\/JNK-Mediated Targeted and Nontargeted Response to Alpha and Auger Radioimmunotherapy. Clin Cancer Res Off J Am Assoc Cancer Res 25(15):4775\u20134790. https:\/\/doi.org\/10.1158\/1078-0432.CCR-18-3295","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"11682_CR17","doi-asserted-by":"publisher","unstructured":"Li M, Zhang J, Xia Y, Cen XT, Zheng Y, Lai W (2022) Development and validation of Cellular Senescence-Related Gene Signature for predicting the survival and immunotherapeutic responses in Skin Cutaneous Melanoma. https:\/\/doi.org\/10.21203\/rs.3.rs-2151455\/v1. In Review","DOI":"10.21203\/rs.3.rs-2151455\/v1"},{"issue":"1","key":"11682_CR18","doi-asserted-by":"publisher","first-page":"44","DOI":"10.3390\/cells8010044","volume":"8","author":"T Rein","year":"2019","unstructured":"Rein T (2019) Is Autophagy Involved in the Diverse Effects of Antidepressants? Cells 8(1):44. https:\/\/doi.org\/10.3390\/cells8010044","journal-title":"Cells"},{"issue":"1","key":"11682_CR19","doi-asserted-by":"publisher","first-page":"107327481879859","DOI":"10.1177\/1073274818798594","volume":"25","author":"AM Bielecka-Wajdman","year":"2018","unstructured":"Bielecka-Wajdman AM, Ludyga T, Machnik G, Go\u0142yszny M, Obuchowicz E (2018) Tricyclic Antidepressants Modulate Stressed Mitochondria in Glioblastoma Multiforme Cells. Cancer Control J Moffitt Cancer Cent 25(1):1073274818798594. https:\/\/doi.org\/10.1177\/1073274818798594","journal-title":"Cancer Control J Moffitt Cancer Cent"},{"issue":"2","key":"11682_CR20","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/ijc.33965","volume":"151","author":"E Petrosyan","year":"2022","unstructured":"Petrosyan E et al (2022) Repurposing autophagy regulators in brain tumors. Int J Cancer 151(2):167\u2013180. https:\/\/doi.org\/10.1002\/ijc.33965","journal-title":"Int J Cancer"},{"issue":"12","key":"11682_CR21","doi-asserted-by":"publisher","first-page":"3301","DOI":"10.3390\/molecules23123301","volume":"23","author":"RT Lima","year":"2018","unstructured":"Lima RT et al (2018) The Antitumor Activity of a Lead Thioxanthone is Associated with Alterations in Cholesterol Localization. Mol Basel Switz 23(12):3301. https:\/\/doi.org\/10.3390\/molecules23123301","journal-title":"Mol Basel Switz"},{"key":"11682_CR22","doi-asserted-by":"publisher","first-page":"218","DOI":"10.3389\/fphar.2018.00218","volume":"9","author":"SK Tan","year":"2018","unstructured":"Tan SK, Jermakowicz A, Mookhtiar AK, Nemeroff CB, Sch\u00fcrer SC, Ayad NG (2018) Drug Repositioning in Glioblastoma: A Pathway Perspective. Front Pharmacol 9:218. https:\/\/doi.org\/10.3389\/fphar.2018.00218","journal-title":"Front Pharmacol"},{"issue":"12","key":"11682_CR23","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1158\/2159-8290.CD-13-0183","volume":"3","author":"NS Jahchan","year":"2013","unstructured":"Jahchan NS et al (2013) A drug repositioning approach identifies tricyclic antidepressants as inhibitors of Small cell lung cancer and other neuroendocrine tumors. Cancer Discov 3(12):1364\u20131377","journal-title":"Cancer Discov"},{"issue":"1","key":"11682_CR24","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s10238-025-01631-0","volume":"25","author":"MS Anwer","year":"2025","unstructured":"Anwer MS, Abdel-Rasol MA, El-Sayed WM (2025) Emerging therapeutic strategies in glioblastsoma: drug repurposing, mechanisms of resistance, precision medicine, and technological innovations. Clin Exp Med 25(1):117. https:\/\/doi.org\/10.1007\/s10238-025-01631-0","journal-title":"Clin Exp Med"},{"issue":"7","key":"11682_CR25","doi-asserted-by":"publisher","first-page":"3982","DOI":"10.1111\/jcmm.15022","volume":"24","author":"F-T Hsu","year":"2020","unstructured":"Hsu F-T, Chiang I-T, Wang W-S (2020) Induction of apoptosis through extrinsic\/intrinsic pathways and suppression of ERK\/NF-\u03baB signalling participate in anti-glioblastoma of imipramine. J Cell Mol Med 24(7):3982\u20134000. https:\/\/doi.org\/10.1111\/jcmm.15022","journal-title":"J Cell Mol Med"},{"issue":"19","key":"11682_CR26","doi-asserted-by":"publisher","first-page":"9350","DOI":"10.1111\/jcmm.16874","volume":"25","author":"Y Wang","year":"2021","unstructured":"Wang Y et al (2021) Imipramine impedes glioma progression by inhibiting YAP as a Hippo pathway independent manner and synergizes with temozolomide. J Cell Mol Med 25(19):9350\u20139363. https:\/\/doi.org\/10.1111\/jcmm.16874","journal-title":"J Cell Mol Med"},{"issue":"2","key":"11682_CR27","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/s12276-020-0389-x","volume":"52","author":"B Alburquerque-Gonz\u00e1lez","year":"2020","unstructured":"Alburquerque-Gonz\u00e1lez B et al (2020) New role of the antidepressant imipramine as a Fascin1 inhibitor in colorectal cancer cells. Exp Mol Med 52(2):281\u2013292. https:\/\/doi.org\/10.1038\/s12276-020-0389-x","journal-title":"Exp Mol Med"},{"key":"11682_CR28","doi-asserted-by":"publisher","unstructured":"Asensi-Cant\u00f3 A, Rodr\u00edguez-Braun E, Beltr\u00e1n-Videla A, Hurtado AM, Conesa-Zamora P (2023) Effects of imipramine on cancer patients over-expressing Fascin1; description of the HITCLIF clinical trial. Front Oncol 13. https:\/\/doi.org\/10.3389\/fonc.2023.1238464","DOI":"10.3389\/fonc.2023.1238464"},{"issue":"1","key":"11682_CR29","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s10238-025-01763-3","volume":"25","author":"H Kariminejad-Farsangi","year":"2025","unstructured":"Kariminejad-Farsangi H, Mirzaee Khalilabadi R, Afgar A, Mirzaie M, Mardani H, Valandani (2025) Microvesicle inhibition enhances the therapeutic effects of ATRA in acute promyelocytic leukemia cells via changes in miRNAs: the promising antileukemic potential of imipramine. Clin Exp Med 25(1):217. https:\/\/doi.org\/10.1007\/s10238-025-01763-3","journal-title":"Clin Exp Med"},{"key":"11682_CR30","doi-asserted-by":"publisher","unstructured":"Asensi-Cant\u00f3 A et al (2022) Antitumoral Effects of Tricyclic Antidepressants: Beyond Neuropathic Pain Treatment. Cancers 14(13). https:\/\/doi.org\/10.3390\/cancers14133248","DOI":"10.3390\/cancers14133248"},{"issue":"32","key":"11682_CR31","doi-asserted-by":"publisher","first-page":"51651","DOI":"10.18632\/oncotarget.10541","volume":"7","author":"KME Laidlaw","year":"2016","unstructured":"Laidlaw KME et al (2016) Cooperation of imipramine blue and tyrosine kinase blockade demonstrates activity against chronic myeloid leukemia. Oncotarget 7(32):51651\u201351664. https:\/\/doi.org\/10.18632\/oncotarget.10541","journal-title":"Oncotarget"},{"issue":"10","key":"11682_CR32","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/s0006-2952(99)00009-x","volume":"57","author":"Z Xia","year":"1999","unstructured":"Xia Z, Lundgren B, Bergstrand A, DePierre JW, N\u00e4ssberger L (1999) Changes in the generation of reactive oxygen species and in mitochondrial membrane potential during apoptosis induced by the antidepressants imipramine, clomipramine, and citalopram and the effects on these changes by Bcl-2 and Bcl-X(L). Biochem Pharmacol 57(10):1199\u20131208. https:\/\/doi.org\/10.1016\/s0006-2952(99)00009-x","journal-title":"Biochem Pharmacol"},{"issue":"6","key":"11682_CR33","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1002\/(SICI)1099-0461(1999)13:6<338::AID-JBT8>3.0.CO;2-7","volume":"13","author":"Z Xia","year":"1999","unstructured":"Xia Z, Bergstrand A, DePierre JW, N\u00e4ssberger L (1999) The antidepressants imipramine, clomipramine, and citalopram induce apoptosis in human acute myeloid leukemia HL-60 cells via caspase-3 activation. J Biochem Mol Toxicol 13(6):338\u2013347. 10.1002\/(SICI)1099-0461(1999)13:6%3C338::AID-JBT8%3E3.0.CO;2-7","journal-title":"J Biochem Mol Toxicol"},{"key":"11682_CR34","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.scr.2017.05.012","volume":"22","author":"B Palodetto","year":"2017","unstructured":"Palodetto B et al (2017) SEMA3A partially reverses VEGF effects through binding to neuropilin-1. Stem Cell Res 22:70\u201378. https:\/\/doi.org\/10.1016\/j.scr.2017.05.012","journal-title":"Stem Cell Res"},{"issue":"1","key":"11682_CR35","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s13046-021-01929-3","volume":"40","author":"E Valentini","year":"2021","unstructured":"Valentini E, Di Martile M, Bufalo DD, D\u2019Aguanno S (2021) SEMAPHORINS and their receptors: focus on the crosstalk between melanoma and hypoxia. J Exp Clin Cancer Res 40(1):131. https:\/\/doi.org\/10.1186\/s13046-021-01929-3","journal-title":"J Exp Clin Cancer Res"},{"issue":"7","key":"11682_CR36","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1002\/ar.24016","volume":"302","author":"Z-G Yang","year":"2019","unstructured":"Yang Z-G et al (2019) The Neuropilin-1 Ligand, Sema3A, Acts as a Tumor Suppressor in the Pathogenesis of Acute Leukemia. Anat Rec 302(7):1127\u20131135. https:\/\/doi.org\/10.1002\/ar.24016","journal-title":"Anat Rec"},{"issue":"2","key":"11682_CR37","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1080\/10428194.2023.2275532","volume":"65","author":"N Meri\u00e7","year":"2024","unstructured":"Meri\u00e7 N, Albayrak E, G\u00fclba\u015f Z, Kocaba\u015f F (2024) MEIS inhibitors reduce the viability of primary leukemia cells and Stem cells by inducing apoptosis. Leuk Lymphoma 65(2):187\u2013198. https:\/\/doi.org\/10.1080\/10428194.2023.2275532","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"11682_CR38","doi-asserted-by":"publisher","first-page":"14404","DOI":"10.1038\/s41598-023-40809-y","volume":"13","author":"Z Omeroglu Ulu","year":"2023","unstructured":"Omeroglu Ulu Z, Degirmenci NS, Bolat ZB, Sahin F (2023) Synergistic anti-cancer effect of sodium pentaborate pentahydrate, curcumin and piperine on hepatocellular carcinoma cells. Sci Rep 13(1):14404","journal-title":"Sci Rep"},{"issue":"1","key":"11682_CR39","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/0022-1759(95)00072-i","volume":"184","author":"I Vermes","year":"1995","unstructured":"Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C (1995) A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods 184(1):39\u201351. https:\/\/doi.org\/10.1016\/0022-1759(95)00072-i","journal-title":"J Immunol Methods"},{"issue":"6","key":"11682_CR40","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1038\/s12276-025-01470-9","volume":"57","author":"SH Dho","year":"2025","unstructured":"Dho SH, Cho M, Woo W, Jeong S, Kim LK (2025) Caspases as master regulators of programmed cell death: apoptosis, pyroptosis and beyond. Exp Mol Med 57(6):1121\u20131132. https:\/\/doi.org\/10.1038\/s12276-025-01470-9","journal-title":"Exp Mol Med"},{"issue":"6","key":"11682_CR41","doi-asserted-by":"publisher","first-page":"2875","DOI":"10.1073\/pnas.040556597","volume":"97","author":"A Hartmann","year":"2000","unstructured":"Hartmann A et al (2000) Caspase-3: A vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson\u2019s disease. Proc Natl Acad Sci U S A 97(6):2875\u20132880. https:\/\/doi.org\/10.1073\/pnas.040556597","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"11682_CR42","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1248\/bpb.28.757","volume":"28","author":"M Kondoh","year":"2005","unstructured":"Kondoh M, Tasaki E, Takiguchi M, Higashimoto M, Watanabe Y, Sato M (2005) Activation of Caspase-3 in HL-60 Cells Treated with Pyrithione and Zinc. Biol Pharm Bull 28(4):757\u2013759. https:\/\/doi.org\/10.1248\/bpb.28.757","journal-title":"Biol Pharm Bull"},{"issue":"4","key":"11682_CR43","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1080\/01926230701320337","volume":"35","author":"S Elmore","year":"2007","unstructured":"Elmore S (2007) Apoptosis: A Review of Programmed Cell Death. Toxicol Pathol 35(4):495\u2013516. https:\/\/doi.org\/10.1080\/01926230701320337","journal-title":"Toxicol Pathol"},{"issue":"1","key":"11682_CR44","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1186\/s12974-020-01902-5","volume":"17","author":"BA McKenzie","year":"2020","unstructured":"McKenzie BA, Fernandes JP, Doan MAL, Schmitt LM, Branton WG, Power C (2020) Activation of the executioner caspases-3 and \u2013\u20097 promotes microglial pyroptosis in models of multiple sclerosis. J Neuroinflammation 17(1):253. https:\/\/doi.org\/10.1186\/s12974-020-01902-5","journal-title":"J Neuroinflammation"},{"issue":"1","key":"11682_CR45","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3892\/ijo.2014.2388","volume":"45","author":"H Wang","year":"2014","unstructured":"Wang H et al (2014) Ultrasound-targeted microbubble destruction combined with dual targeting of HSP72 and HSC70 inhibits HSP90 function and induces extensive tumor-specific apoptosis. Int J Oncol 45(1):157\u2013164. https:\/\/doi.org\/10.3892\/ijo.2014.2388","journal-title":"Int J Oncol"},{"issue":"7Supplement","key":"11682_CR46","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1158\/1538-7445.AM2023-1665","volume":"83","author":"PP Venkata","year":"2023","unstructured":"Venkata PP et al (2023) Abstract 1665: Imipramine enhances the efficacy of lomustine by regulating WNT-\u03b2-catenin signaling in glioblastoma. Cancer Res 83(7Supplement):1665\u20131665","journal-title":"Cancer Res"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11682-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-11682-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11682-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T12:14:44Z","timestamp":1773836084000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-11682-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,18]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["11682"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-11682-5","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,18]]},"assertion":[{"value":"16 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"declarations.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}],"article-number":"508"}}